Monocular Action Video Game Treatment of Amblyopia
Study Details
Study Description
Brief Summary
This study evaluates the effectiveness of the monocular treatment with action video-games in comparison with the occlusion therapy alone in amblyopic patients, and the satisfaction with the different evaluated treatments.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Amblyopia is the condition in which there is a decrease in monocular visual acuity or, less frequently, binocular, in absence of structural anomalies or ocular pathology. It is a reversible condition that affects up to 5% of the population, and that is the result of an abnormal visual experience during the most sensitive period of visual development.
The aim of this study is reviewing, analyzing and, if applicable, updating the current treatment model for amblyopia.
A randomized clinical trial will be performed to evaluate the effectiveness of the monocular treatment with action video-games in comparison with the occlusion therapy alone in amblyopic patients, and the satisfaction with the different evaluated treatments. The participants will be distributed in two groups. The first group will include those participants who will follow a daily occlusive treatment and the second group will include patients who will be treated with monocular therapy with video-games.The sample will include subjects between 4 to 10 years old with a diagnosis of refractive and / or strabismic amblyopia.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Passive Occlusion This arm will include those participants who will follow a daily occlusive treatment of 2 hours. |
Other: Monocular Passive Occlusion
Occlusion treatment of two hour daily.
|
Experimental: Active Occlusion This arm will include patients who will be treated with monocular therapy with video-games of one hour on a daily regimen. |
Other: Monocular Active Occlusion
Occlusion treatment of one hour daily with action video game.
|
Outcome Measures
Primary Outcome Measures
- Change from baseline visual acuity (VA) at 14 hours , 28 hours , and 42 hours comparing passive occlusion vs active occlusion (with action video games). [Baseline and 14, 28 and 42 hours post treatment.]
Visual Acuity (VA in logMAR) will be evaluated by E Snellen Test through an Ipad and the app AmblyopiaVA. The AmblyopiaVA test is designed based on the standard protocol for measuring Visual Acuity in children with Amblyopia.The measure will be performed at 2 m.
- Change from baseline stereopsis (ST) at 14 hours , 28 hours , and 42 hours comparing passive occlusion vs active occlusion (with action video games). [Baseline and 14, 28 and 42 hours post treatment.]
Stereopsis (ST in logMAR) will be evaluated by a Multiple Random Points test through an Ipad, the app StereoTAB and anaglyphic glasses. The measures will be performed at 50 cm.
- Change from baseline contrast sensitivity function (CSF) at 14 hours , 28 hours , and 42 hours comparing passive occlusion vs active occlusion (with action video games). [Baseline and 14, 28 and 42 hours post treatment.]
The effect of treatment on Contrast Sensitivity Function (CSF in logMAR) will be evaluated by ClinicCFS test using sine grids of four different spatial frequencies: 3, 6, 12 and 18 cpd.
Secondary Outcome Measures
- Satisfaction assessed by an ordinal questionnaire designed based on the Treatment Satisfaction Questionnaire for Medication (TSQM). [42 hours]
Satisfaction assessed by an ordinal questionnaire (1 to 5, as 1 the lowest satisfaction and 5 the highest satisfaction),based on the TSQM (Treatment Satisfaction Questionnaire for Medication) version 1.4 to provide data regarding the degree of satisfaction and sensation of parents and children in relation to treatment.
- Rate of Compliance comparing passive occlusion vs active occlusion (with action video games) assessed by Google Analytics and written questionnaire. [Baseline and 14h, 28h and 42 hours.]
Rate of Compliance assessed through the registration of parent-reported adherence and log file data in Google Analytics (descriptive scale of time in hours/day) for active group and parent's questionnaire for passive group (subjective scale in hours/day)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age 4-10 years old
-
Anisometropic amblyopia
-
Strabismic amblyopia or mixed
-
Interocular visual acuity (VA) difference of at least 0.2 logMAR
-
No history of eye surgery
Exclusion Criteria:
-
Non-comitant and/or large constant strabismus (>30 prism diopters)
-
Any ocular pathological condition or nystagmus
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Laura Asensio Jurado | Barcelona | Spain |
Sponsors and Collaborators
- Universitat Politècnica de Catalunya
- Hospital Mutua de Terrassa
- Parc Sanitari Sant Joan de Déu
Investigators
- Principal Investigator: Laura Asensio Jurado, MsC, Universitat Politècnica de Catalunya
- Study Director: Marc Argilés Sans, PhD, Universitat Politècnica de Catalunya
- Study Director: Lluïsa Quevedo i Junyent, PhD, Universitat Politècnica de Catalunya
Study Documents (Full-Text)
None provided.More Information
Publications
- Bavelier D, Green CS, Pouget A, Schrater P. Brain plasticity through the life span: learning to learn and action video games. Annu Rev Neurosci. 2012;35:391-416. doi: 10.1146/annurev-neuro-060909-152832. Review.
- Bediou B, Adams DM, Mayer RE, Tipton E, Green CS, Bavelier D. Meta-analysis of action video game impact on perceptual, attentional, and cognitive skills. Psychol Bull. 2018 Jan;144(1):77-110. doi: 10.1037/bul0000130. Epub 2017 Nov 27. Erratum in: Psychol Bull. 2018 Sep;144(9):978-979.
- Gambacorta C, Nahum M, Vedamurthy I, Bayliss J, Jordan J, Bavelier D, Levi DM. An action video game for the treatment of amblyopia in children: A feasibility study. Vision Res. 2018 Jul;148:1-14. doi: 10.1016/j.visres.2018.04.005. Epub 2018 May 12.
- Li RW, Ngo C, Nguyen J, Levi DM. Video-game play induces plasticity in the visual system of adults with amblyopia. PLoS Biol. 2011 Aug;9(8):e1001135. doi: 10.1371/journal.pbio.1001135. Epub 2011 Aug 30.
- PhDLAJE1